Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Myosotis

Explore full profile

A communication platform for the care sector

Berlin, GermanyFounded 2017Health Tech & Medtech
Valuation $50–100M Last recorded · 2024
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Myosotis and the history behind them.

About Myosotis

Myosotis, operating under the brand MYO, is a German health-tech company that has developed a communication and organization platform specifically for the nursing and care sector. Founded in 2018 by Jasper Böcker and Felix W T. Wenzel, the company aims to address the communication inefficiencies and documentation burdens prevalent in inpatient and outpatient care facilities. The founders' backgrounds are complementary; Böcker brings experience from the Boston Consulting Group, focusing on digital transformation in the healthcare sector, while Wenzel has a background in building digital platforms. The core of MYO's offering is a GDPR-compliant software-as-a-service (SaaS) application designed to connect caregivers, doctors, relatives, and other stakeholders involved in a patient's care. The platform facilitates secure messaging, digital handover reports, and the sharing of important documents and updates, effectively replacing outdated methods like fax machines, paper notes, and telephone chains. This digital approach aims to save time for nursing staff, allowing them to focus more on direct patient care. The business model is based on subscriptions, with care facilities paying a monthly fee to use the platform. MYO's service streamlines daily routines by centralizing information and making it accessible via smartphones, tablets, or desktop computers. Key features include a digital resident file, a handover book, and a secure chat function for quick coordination. By digitizing these processes, the platform not only enhances efficiency but also improves the quality and documentation of care. The company has seen significant adoption, with several thousand care facilities across Germany utilizing its services.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2017
Headquarters
Berlin, Germany
Employees
45
Open positions
7
Dealroom signal
82.8/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Senior Citizens, Tech for Hospitals and Clinics, Tech for Medical Professionals, Physician Support Tools, Health Office Tools, Hard Tech, Health It
Client focus
b2b

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2024 $8.8M $35M BONVENTURE · Capacura · Mountain Partners · Axel Springer Plug and Play Accelerator ↗
SEED✓Equity / VC Nov 2020 $1.1M $8.3M BONVENTURE —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Myosotis website traffic

Latest recorded traffic for Myosotis is 1.5K monthly website visits, up 0% over the last three months. Myosotis's team grew 18.4% over the past year.

Latest monthly visits1.5K 3-month web change0% 1-year team growth+18.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • Think.Health
  • BONVENTURE

Series A8 investors entered at this stage

  • Capacura
  • Mountain Partners
  • Axel Springer Plug and Play Accelerator
  • Round Hill Ventures
  • Twip Impact Ventures
  • Senioren-Park carpe diem
  • TVM Capital Life Science
  • Agaplesion

Other known investors1 additional known investor

  • Marc penkala
Team profiled 12 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇩🇪 Germany75%
🇭🇷 Croatia10.7%
🇪🇪 Estonia3.6%
🇳🇴 Norway3.6%
🇵🇹 Portugal3.6%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Myosotis on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Myosotis’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.